Patients taking febuxostat after the control of uric acid to the normal reference range is recommended to maintain the minimum dose of medication, is generally not recommended to stop the drug. Consult your doctor for specific dosage recommendations. Febuxostat is a kind of xanthine oxidase inhibitor through inhibiting uric acid synthesis to reduce the level of uric acid concentration in the patient’s body, generally used for long-term treatment of gout patients with hyperuricemia, patients taking the drug uric acid control to reach the standard is recommended to maintain the minimum dose of maintenance therapy, it is not recommended to stop taking the drug so as not to cause the fluctuation of the body’s concentration of uric acid level leading to recurrence or aggravation of the disease. Febuxostat is a prescription drug, it is not recommended that patients take, stop or increase or decrease the dose of the drug, common adverse reactions include liver function abnormalities, nausea, arthralgia, skin rash. It is contraindicated in patients being treated with azathioprine or mercaptopurine. Note that liver and renal function and blood uric acid level should be monitored regularly during drug administration. If it is necessary to stop taking Febuxostat due to factors such as changes in the condition, it should be done under the supervision of a physician. It is recommended that patients taking febuxostat go to the rheumatology and immunology department of regular hospitals for detailed consultation, and do not stop taking the drug without authorization.